AstraZeneca plc (AZN) stock is lower by -5.85% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AZN stock a score of 59 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 62. AZN's rank also includes a long-term technical score of 57. AZN has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on AZN!